SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-20-053547
Filing Date
2020-04-29
Accepted
2020-04-29 17:12:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 tm2018023d1_424b3.htm 424B3 115373
2 GRAPHIC image_001.jpg GRAPHIC 3165
3 GRAPHIC image_002.jpg GRAPHIC 3837
  Complete submission text file 0001104659-20-053547.txt   126510
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-237736 | Film No.: 20831614
SIC: 2836 Biological Products, (No Diagnostic Substances)